Market Tracker

10/31 10:00pm ET

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

3.23
Data as of Oct 31
 -0.11 / -3.29%
Today’s Change
2.68
Today|||52-Week Range
5.25
-19.65%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close3.34
Today’s open3.36
Day’s range3.19 - 3.46
Volume111,437
Average volume (3 months)99,201
Market cap$73.2M
Dividend yield--
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)+23.81%
Earnings growth (this year)+23.05%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,471.01%
P/E ratioNM
Price/Sales56.21
Price/Book2.23

Competitors

 Today’s
change
Today’s
% change
GLMDGalmed Pharmaceutica...-0.05-0.75%
ARQLArQule Inc-0.02-1.71%
ORMPOramed Pharmaceutica...-0.22-2.97%
AQXPAquinox Pharmaceutic...-0.48-6.75%
Data as of 3:59pm ET, 10/31/2014

Financials

Next reporting dateNovember 17, 2014
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$1.1M
Annual profit (last year)-$10.2M
Net profit margin-941.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts